Triumph Capital Management’s Fresenius Medical Care FMS Stock Holding History
Bought
Maintained
Sold
Other funds holding FMS
Triumph Capital Management's FMS Position: Q3 2026 in Review
Triumph Capital Management held its Fresenius Medical Care (FMS) position steady in Q3 2026 at 3 shares worth $67. The position accounts for ﹤0.01% of the portfolio, ranked #1883.
Triumph Capital Management first reported a position in FMS in Q1 2026 and has held it in 3 quarters since. The position peaked at $68 in Q2 2026. 229 funds tracked by Wall St. Rank hold FMS as of Q3 2026.
- Triumph Capital Management held 3 shares of Fresenius Medical Care worth $67 as of Q3 2026.
- Triumph Capital Management left its Fresenius Medical Care share count unchanged in Q3 2026.
- Fresenius Medical Care made up ﹤0.01% of Triumph Capital Management's portfolio in Q3 2026, its #1883 holding.
- Triumph Capital Management first reported a position in Fresenius Medical Care in Q1 2026 and has held it in 3 quarters since.
- Triumph Capital Management's Fresenius Medical Care position peaked at $68 in Q2 2026.
- 229 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q3 2026.
Based on Triumph Capital Management's 13F filing for Q3 2026, filed 14 Oct 2026.